Aripiprazole Lauroxil, a novel injectable long-acting antipsychotic treatment for adults with schizophrenia: a comprehensive review

K Maini, H Gould, J Hicks, F Iqbal, J Patterson… - Neurology …, 2021 - mdpi.com
Purpose of Review. This is a comprehensive review of the literature regarding the use of
Aripiprazole lauroxil for schizophrenia. This review presents the background, evidence, and …

Aripiprazole lauroxil: a review in schizophrenia

JE Frampton - Drugs, 2017 - Springer
Aripiprazole lauroxil long-acting injectable (LAI)[Aristada®] is an intramuscularly
administered, extended-release prodrug of aripiprazole, an established atypical …

Effectiveness of SGA-LAIs on clinical, cognitive, and social domains in schizophrenia: results from a prospective naturalistic study

R de Filippis, FA Staltari, M Aloi, EA Carbone, M Rania… - Brain Sciences, 2023 - mdpi.com
We hypothesized that shifting from oral second-generation antipsychotics (SGA) to their long-
acting injectable (LAI) counterpart would be beneficial for the psychopathological, cognitive …

Head-to-head comparison of 1-year aripiprazole long-acting injectable (LAI) versus paliperidone LAI in comorbid psychosis and substance use disorder: impact on …

I Cuomo, GD Kotzalidis, S de Persis… - Neuropsychiatric …, 2018 - Taylor & Francis
Background To overcome nonadherence in patients with psychosis switch to long-acting
injectable (LAI) antipsychotic formulations is adopted. Most oral versus LAI comparisons …

Paliperidone palmitate versus risperidone long-acting injectable in patients with schizophrenia: a meta-analysis of efficacy and safety

M Zhao, B Qin, Y Mao, Y Zhang, R Zhao… - Neuropsychiatric …, 2023 - Taylor & Francis
Purpose The aim of this study was to assess the efficacy and safety of paliperidone palmitate
(PP) treatment compared with risperidone long-acting injectable (LAI) treatments for patients …

Применение антипсихотиков длительного действия при шизофрении

ЖБ Бибекова, ЕА Стрельцов… - … вестник Юга России, 2020 - cyberleninka.ru
В настоящем обзоре литературы рассмотрены вопросы эффективности и
безопасности терапии антипсихотиками длительного действия при шизофрении …

[HTML][HTML] Atypical injectable antipsychotics for schizophrenia or bipolar disorder: a review of clinical effectiveness and cost-effectiveness

T Narain, C Ford - 2019 - europepmc.org
Atypical injectable antipsychotics are second-generation therapeutics that can be used as
an alternative to first-generation antipsychotics to treat patients with schizophrenia or bipolar …

APPLICATION OF ANTIPSYCHOTICS OF LONG-TERM ACTION IN SCHIZOPHRENIA

ZB Bibekova, EA Strel'cov… - Medical Herald of the …, 2020 - medicalherald.ru
This literature review addresses the effectiveness and safety of long-acting antipsychotic
therapy for schizophrenia. The results of randomized trials of recent years are described in …

Medication and healthcare resource utilization among Texas Medicaid patients with schizophrenia prescribed second generation antipsychotic long-acting injectables

S Chen - 2023 - repositories.lib.utexas.edu
Schizophrenia is a severe mental health condition that presents a significant societal burden
due to cognitive and functional deterioration, which negatively impacts work productivity and …

Avaliación dos pacientes duais con trastornos psicóticos comórbidos en programa de tratamento con antipsicóticos inxectables de longa duración

L Mato Gómez - minerva.usc.es
A patoloxía dual defínese como a coexistencia, no mesmo individuo, dun trastorno aditivo
máis un trastorno mental comórbido. Dentro destes últimos, os trastornos psicóticos …